help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chambers, T. J.
Right arrow Articles by Fuller, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chambers, T. J.
Right arrow Articles by Fuller, K.

Endocrinology, Vol 116, 234-239, Copyright © 1985 by Endocrine Society


ARTICLES

The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones

TJ Chambers, PM McSheehy, BM Thomson and K Fuller

It has previously only been possible to assess osteoclastic bone resorption in intact bone, where other cell types may modify or mediate osteoclastic responses to environmental agents. We have recently developed techniques which enable us to measure bone resorption by osteoclasts extracted from bone and have used these techniques to assess the effects of prostaglandins (PGs) and calcium-regulating hormones on bone resorption by these cells. Osteoclasts were mechanically disaggregated from neonatal rabbit long bones and cultured on slices of devitalized cortical bone for 8 or 24 h. After this time, osteoclasts were associated with the appearance in the scanning electron microscope of characteristic resorption pits, the volume of which was calculated by computer-assisted morphometric and stereophotogrammetric techniques after removal of cells. Salmon calcitonin inhibited osteoclastic bone resorption at concentrations of 1 pg/ml and above, while PTH and 1,25-dihydroxyvitamin D3 were without significant effect. This suggests that the latter hormones do not increase bone resorption in intact bone through a direct effect on osteoclasts. PGI2, PGE1, and PGE2, all of which are known to stimulate resorption when added to intact bone, paradoxically reduced resorption in our cultures. It appears likely that PGs act as direct inhibitors of osteoclastic bone resorption but have an additional effect on other cells in bone, which are induced by PGs to cause osteoclastic stimulation.


This article has been cited by other articles:


Home page
EndocrinologyHome page
K. Fuller, B. Kirstein, and T. J. Chambers
Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents
Endocrinology, April 1, 2006; 147(4): 1979 - 1985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Okamoto, H. Kajiya, H. Fukushima, E. Jimi, and K. Okabe
Prostaglandin E2 activates outwardly rectifying Cl- channels via a cAMP-dependent pathway and reduces cell motility in rat osteoclasts
Am J Physiol Cell Physiol, July 1, 2004; 287(1): C114 - C124.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. Hirayama, L. Danks, A. Sabokbar, and N. A. Athanasou
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis
Rheumatology, November 1, 2002; 41(11): 1232 - 1239.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Fuller, C. Murphy, B. Kirstein, S. W. Fox, and T. J. Chambers
TNF{alpha} Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL
Endocrinology, March 1, 2002; 143(3): 1108 - 1118.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. M. Lean, K. Fuller, and T. J. Chambers
FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function
Blood, November 1, 2001; 98(9): 2707 - 2713.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. Bhandari, A. Adili, and E. H. Schemitsch
The Efficacy of Low-Pressure Lavage with Different Irrigating Solutions to Remove Adherent Bacteria from Bone
J. Bone Joint Surg. Am., March 1, 2001; 83(3): 412 - 412.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Mano, C. Kimura, Y. Fujisawa, T. Kameda, M. Watanabe-Mano, H. Kaneko, T. Kaneda, Y. Hakeda, and M. Kumegawa
Cloning and Function of Rabbit Peroxisome Proliferator-activated Receptor delta /beta in Mature Osteoclasts
J. Biol. Chem., March 10, 2000; 275(11): 8126 - 8132.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. M. PEET, P. S. GRABOWSKI, I. LAKETIC-LJUBOJEVIC, and T. M. SKERRY
The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation
FASEB J, December 1, 1999; 13(15): 2179 - 2185.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. R. Wani, K. Fuller, N. S. Kim, Y. Choi, and T. Chambers
Prostaglandin E2 Cooperates with TRANCE in Osteoclast Induction from Hemopoietic Precursors: Synergistic Activation of Differentiation, Cell Spreading, and Fusion
Endocrinology, April 1, 1999; 140(4): 1927 - 1935.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
K. Fuller, B. Wong, S. Fox, Y. Choi, and T. J. Chambers
TRANCE Is Necessary and Sufficient for Osteoblast-mediated Activation of Bone Resorption in Osteoclasts
J. Exp. Med., September 7, 1998; 188(5): 997 - 1001.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Naro, M. Perez, S. Migliaccio, D. L. Galson, P. Orcel, A. Teti, and S. R. Goldring
Phospholipase D- and Protein Kinase C Isoenzyme-Dependent Signal Transduction Pathways Activated by the Calcitonin Receptor
Endocrinology, July 1, 1998; 139(7): 3241 - 3248.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. J. Suva, M. S. Flannery, M. P. Caulfield, D. M. Findlay, H. Jüppner, S. R. Goldring, M. Rosenblatt, and M. Chorev
Design, Synthesis and Utility of Novel Benzophenone-Containing Calcitonin Analogs for Photoaffinity Labeling the Calcitonin Receptor
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 876 - 884.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
S. Meghji, P. A. White, S. P. Nair, K. Reddi, K. Heron, B. Henderson, A. Zaliani, G. Fossati, P. Mascagni, J. F. Hunt, et al.
Mycobacterium tuberculosis Chaperonin 10 Stimulates Bone Resorption: A Potential Contributory Factor in Pott's Disease
J. Exp. Med., October 20, 1997; 186(8): 1241 - 1246.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Roux, F. Pichaud, J. Quinn, A. Lalande, C. Morieux, A. Jullienne, and M.-C. de Vernejoul
Effects of Prostaglandins on Human Hematopoietic Osteoclast Precursors
Endocrinology, April 1, 1997; 138(4): 1476 - 1482.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
N. A. ATHANASOU
Current Concepts Review - Cellular Biology of Bone-Resorbing Cells
J. Bone Joint Surg. Am., July 1, 1996; 78(7): 1096 - 1112.
[Full Text]


Home page
J. Biol. Chem.Home page
A. Teti, R. Paniccia, and S. R. Goldring
Calcitonin Increases Cytosolic Free Calcium Concentration via Capacitative Calcium Influx
J. Biol. Chem., July 14, 1995; 270(28): 16666 - 16670.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K Fuller and T. Chambers
Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts
J. Cell Sci., January 6, 1995; 108(6): 2221 - 2230.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society